Posts

Lower Back Pain Is Rarely a Cancer Sign—But It Can Be

Image
newest treatment for multiple myeloma 2020 :: Article Creator Multiple Myeloma News Oct. 8, 2024 — A new tool detects the evolutionary advantages of multiple myeloma cells over the different treatments available. The information it provides can help prevent the tumor from becoming resistant to ... Dec. 11, 2022 — A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical ... Nov. 4, 2022 — Researchers have identified therapies that can help patients with the blood cancer multiple myeloma who try an immunotherapy known as CAR-T only to find their cancer coming back ... Sep. 6, 2022 — New CT technology paired with artificial intelligence (AI)-based noise reduction offers superior detection of bone disease associated with multiple myeloma at lower radiation doses than conventional ... Sep. 1, 2022 — Researchers have published results that show encouragin

7 pain management options for cancer patients you might not know about

Image
mammo diagnostic :: Article Creator R&B Singer Shanice Says She Was Diagnosed With Breast Cancer After Skipping Mammogram For 8 Years R&B singer Shanice is sharing new details of her breast cancer journey, revealing she was diagnosed with the disease after avoiding mammograms for nearly a decade. "I just want to tell women how important it is to get your mammograms," Shanice said Wednesday on "Good Morning America," adding, "If I would have gone sooner, I could have caught [my breast cancer diagnosis] when it was just at stage zero." The "I Love Your Smile" singer said she had a health scare in her mid-40s when doctors thought she had a cancerous lump in her breast. Doctors determined the lump was a cyst that didn't require further testing, but Shanice, now 51, said the scare deterred her from getting screened annually for breast cancer. "Because of the fear that I had when they though

A Family’s Perspective – “The Brutality of Sepsis will Haunt Us for the Rest of Our Lives”

Image
diet after bladder removal :: Article Creator What Can Ease Digestion After A Gall Bladder Removal? Can you eat what you like when you have just had your gallbladder out? The surgeon said I could, but I am having terrible digestive problems and feel extremely nauseous most of the time. Anything you could suggest would be extremely useful, thanks. {"status":"error","code":"499","payload":"Asset id not found: readcomments comments with assetId=138530, assetTypeId=1"} Bladder Cancer Treatment

Pinpointing pain: Is it cancer or cancer treatment?

Image
nursing diagnosis for testicular cancer :: Article Creator Testicular Cancer CURE's testicular cancer page features the latest cancer news and updates on testicular cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in testicular cancer. Surveillance Or Biopsy For Men With Testicular Microlithiasis? Cite this article Farley, S. Surveillance or biopsy for men with testicular microlithiasis?. Nat Rev Urol 7, 478 (2010). Https://doi.Org/10.1038/nrurol.2010.135 Download citation Share this article Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative Testicular Cancer Articles From Across Nature Portfolio Serum tumour marker

Can watery eyes be a sign of cancer?

Image
brain radiation :: Article Creator The Deadliest Kind Of Brain Cancer May Have A Promising New Treatment Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis – the average survival after diagnosis is between 12 and 15 months. And just 6.9% of patients survive beyond five years, making it one of the most poorly survived cancers. The toll this cancer takes goes beyond survival rates. Patients can suffer from symptoms like headaches, seizures, cognitive and personality changes, and neurological impairments. These symptoms may drastically affect their quality of life. But despite the urgent need, no targeted treatments exist for this devastating disease. Researchers now believe that immunotherapy, which harnesses the immune system to target cancer cells, could be a turning point in the treatment of glioblastoma. Glioblastoma is a naturally occurring tumour that belongs to a group of

Lower Back Pain Is Rarely a Cancer Sign—But It Can Be

Image
prostate cancer medical treatment :: Article Creator Prostate Cancer Breakthroughs And 9 Remarkable Ways Vitamin K May Aid Treatment Prostate cancer research has taken a groundbreaking leap as scientists at Cold Spring Harbor Laboratory (CSHL) in New York uncover a potential game-changer in treatment approaches. Their study, recently published in Science, reveals how a pro-oxidant supplement derived from vitamin K could revolutionize the fight against this prevalent form of cancer, sending ripples through the medical community. The power of menadione At the heart of this discovery lies menadione, a precursor of vitamin K that has shown remarkable ability to target and eliminate prostate cancer cells. This compound operates through a unique mechanism that exploits a vulnerability specific to cancer cells, offering a more definitive solution compared to traditional treatments like radiation therapy. Unraveling the cellular chaos The study's f

What are the top 5 warning signs of prostate cancer?

Image
hcc treatment :: Article Creator TARE In Advanced HCC: When Is It Optimal And Why? Jin Woo Choi, MD, PhDSeoul National University Hospital Seoul National UniversitySeoul, Republic of Koreajwchoi.Med@snu.Ac.KrDisclosures: None. Transarterial radioembolization (TARE) can be considered for patients with unilobar hepatocellular carcinoma (HCC) and ipsilateral portal vein tumor thrombosis (Vp1-3), provided there is no hepatic vein invasion, no extrahepatic spread, Child-Pugh A status, and an ECOG (Eastern Cooperative Oncology Group) performance status of 0 to 1. Although this represents an advanced stage of HCC, locoregional treatments may still be viable, and an effective locoregional treatment can potentially increase the likelihood of curative outcomes. Despite the rapid development of immune checkpoint inhibitors, which are now the frontline treatment for advanced HCC, there is a significant lack of detailed data for this specific patient popul